Evidence map›Paper›PMID 36670183›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2023

[The athlete's ECG : What is normal or abnormal?]

Amaar Ujeyl, David Niederseer

Erratum issuedAbstract readEnglish AbstractReview
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

  • Erratum issued
    2023
5 · Who and what money

Authors and funding

2 authors.

Amaar UjeylPraxis LANS Cardio, Hamburg, Deutschland.
David NiederseerKlinik für Kardiologie, Universitäres Herzzentrum Zürich, Universitätsspital Zürich, Universität Zürich, Rämistrasse 100, Zürich, 8091, Schweiz. david.niederseer@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe electrocardiogram (ECG) has become a mobile and cost-effective routine assessment tool to risk stratify leisure-time and professional athletes during preparticipation screening. A central goal is the reduction of sudden cardiac death in sports through early recognition of the most prevalent underlying cardiac pathologies, e.g., hereditary cardiomyopathies or primary arrhythmias.

methodsContinuous evolution of the first ECG criteria for athletes, presented in 2010 by the European Society of Cardiology (ESC), has helped to improve the specificity of the criteria to both detect cardiac pathologies in early stages and differentiate from physiologic adaptation of the athlete's heart. Thus, the risk of false-positive findings and erroneous stigmatizations of athletes has been successfully reduced.

conclusionThis review article intends to trace back the changes of the ECG criteria in the light of a growing body of scientific evidence over the last 15 years, to present the key messages of the current International ECG criteria from 2017 and to identify some of the remaining challenges that wait to be answered by physicians in the field of sports medicine and sports cardiology.

Indexed as

CardiomyopathiesSportsAthletesDeath, Sudden, CardiacElectrocardiographyHeartHumansMass ScreeningAthlete’s heartElectrocardiogramElite sportsSports cardiologySudden cardiac death

Identifiers

PMID36670183
PMCPMC9950162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.